Comparison of Single Trocar Cholecystectomy to Standard Laparoscopic Cholecystectomy
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to determine the advantages of single trocar cholecystectomy over standard laparoscopic cholecystectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 3, 2008
CompletedFirst Posted
Study publicly available on registry
August 12, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedJuly 30, 2020
April 1, 2016
10.2 years
August 3, 2008
July 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess the safety and efficacy of a novel approach to minimally invasive surgery techniques.
Continuous
Secondary Outcomes (2)
To assess pain associated with the single trocar approach
Continuous
To assess scar formation associated with single trocar approach
Continuous
Study Arms (2)
Single trocar
EXPERIMENTALPatients will undergo cholecystectomy by the single trocar approach
Standard lap cholecystectomy
ACTIVE COMPARATORStandard lap choly
Interventions
Patients with symptomatic cholelithiasis will be operated using the single trocar surgery approach
Patients with symptomatic cholelithiasis will undergo a standard laparoscopic cholecystectomy
Eligibility Criteria
You may qualify if:
- Age 18-60
- symptomatic cholelithiasis
- ASA 1-2
You may not qualify if:
- pregnancy
- morbid obesity with BMI\>35
- other gallbladder pathology like polyps or tumor
- history of upper abdomen laparotomy
- suspected choledocholithiasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization Ein-Kerem campus
Jerusalem, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yoav Mintz, MD
Hadassah Medical Organization
- STUDY CHAIR
Avraham Rivkind, MD
Hadassah Medical Organization
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2008
First Posted
August 12, 2008
Study Start
July 1, 2008
Primary Completion
September 1, 2018
Study Completion
September 1, 2018
Last Updated
July 30, 2020
Record last verified: 2016-04